These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 31730505)
1. Acellular Fish Skin Graft Use for Diabetic Lower Extremity Wound Healing: A Retrospective Study of 58 Ulcerations and a Literature Review. Michael S; Winters C; Khan M Wounds; 2019 Oct; 31(10):262-268. PubMed ID: 31730505 [TBL] [Abstract][Full Text] [Related]
2. Treatment of diabetic foot wounds with acellular fish skin graft rich in omega-3: a prospective evaluation. Woodrow T; Chant T; Chant H J Wound Care; 2019 Feb; 28(2):76-80. PubMed ID: 30767649 [TBL] [Abstract][Full Text] [Related]
3. A Prospective, Postmarket, Compassionate Clinical Evaluation of a Novel Acellular Fish-skin Graft Which Contains Omega-3 Fatty Acids for the Closure of Hard-to-heal Lower Extremity Chronic Ulcers. Yang CK; Polanco TO; Lantis JC Wounds; 2016 Apr; 28(4):112-8. PubMed ID: 27071138 [TBL] [Abstract][Full Text] [Related]
4. Fish Skin Grafts with Omega-3 for Treatment of Chronic Wounds: Exploring the Role of Omega-3 Fatty Acids in Wound Healing and A Review of Clinical Healing Outcomes. Seth N; Chopra D; Lev-Tov H Surg Technol Int; 2022 May; 40():38-46. PubMed ID: 35483381 [TBL] [Abstract][Full Text] [Related]
5. A multicenter retrospective study comparing a polylactic acid CAMP with intact fish skin graft or a collagen dressing in the management of diabetic foot ulcers and venous leg ulcers. Liden BA; Liu T; Regulski M; Foster M; DeLeon R; Palazzi G; Ramirez-GarciaLuna JL Wounds; 2024 Sep; 36(9):297-302. PubMed ID: 39378347 [TBL] [Abstract][Full Text] [Related]
6. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers. Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000 [TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150 [TBL] [Abstract][Full Text] [Related]
8. Human Reticular Acellular Dermal Matrix in the Healing of Chronic Diabetic Foot Ulcerations that Failed Standard Conservative Treatment: A Retrospective Crossover Study. Zelen CM; Orgill DP; Serena TE; Galiano RD; Carter MJ; DiDomenico LA; Kaufman JP; Keller J; Young NJ; Li WW Wounds; 2017 Feb; 29(2):39-45. PubMed ID: 28272011 [TBL] [Abstract][Full Text] [Related]
9. Healing rate and autoimmune safety of full-thickness wounds treated with fish skin acellular dermal matrix versus porcine small-intestine submucosa: a noninferiority study. Baldursson BT; Kjartansson H; Konrádsdóttir F; Gudnason P; Sigurjonsson GF; Lund SH Int J Low Extrem Wounds; 2015 Mar; 14(1):37-43. PubMed ID: 25759413 [TBL] [Abstract][Full Text] [Related]
10. A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers. Lullove EJ; Liden B; Winters C; McEneaney P; Raphael A; Lantis Ii JC Wounds; 2021 Jul; 33(7):169-177. PubMed ID: 33872197 [TBL] [Abstract][Full Text] [Related]
11. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis. Reyzelman AM; Bazarov I J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of acellular fish skin graft in the management of chronic ulcer: a systematic review and meta-analysis. Gao J; Ge LX; Gao QY; Zhang AM; Hu LJ Langenbecks Arch Surg; 2024 Feb; 409(1):64. PubMed ID: 38363369 [TBL] [Abstract][Full Text] [Related]
14. The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study. Kavros SJ; Dutra T; Gonzalez-Cruz R; Liden B; Marcus B; McGuire J; Nazario-Guirau L Adv Skin Wound Care; 2014 Aug; 27(8):356-62. PubMed ID: 25033310 [TBL] [Abstract][Full Text] [Related]
15. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers. Cazzell S Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443 [TBL] [Abstract][Full Text] [Related]
16. Use of a human acellular dermal wound matrix in patients with complex wounds and comorbidities. Williams ML; Holewinski JE J Wound Care; 2015 Jun; 24(6):261-2, 264-7. PubMed ID: 26075374 [TBL] [Abstract][Full Text] [Related]
17. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357 [TBL] [Abstract][Full Text] [Related]
18. Use of three-dimensional acellular collagen matrix in deep or tunnelling diabetic foot ulcers: a retrospective case series. Abdo RJ; Couch AL J Wound Care; 2024 Sep; 33(Sup9):S5-S16. PubMed ID: 39283885 [TBL] [Abstract][Full Text] [Related]
19. Human-derived Acellular Dermal Matrix Grafts for Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-analysis. Luthringer M; Mukherjee T; Arguello-Angarita M; Granick MS; Alvarez OM Wounds; 2020 Feb; 32(2):57-65. PubMed ID: 32155123 [TBL] [Abstract][Full Text] [Related]
20. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial. Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]